Objective: The natural polyamines play a protective role during ischemic injury. We stud ied the effects of agmatine on ischemic and nonischemic isolated rat hearts.
Methods: Thirty-one rats were randomly assigned to one of four experimental groups. Six teen rats were injected with saline (group 1, n = 9; group 3, n = 7), and 15 rats were injected with 100 mg/kg of agmatine (group 2, n = 8; group 4, n = 7). Injections were given twice: 24 hours and 1 hour before the experiment. Using the modified Langendorf model, rat hearts were perfused with Krebs-Henseleit solution for 105 minutes during phase 1 of the experi ment (groups 1 and 2). During phase 2, hearts were exposed to 45 minutes of global ischemia (groups 3 and 4).
Results: During phase 1, no statistically significant differences were observed between the agmatine and the control groups. During phase 2, agmatine caused a significant increase in left ventricular pressure (P < .003). At the end of reperfusion, P(max) was 111 % ± 10% from the baseline levels versus only 82% ± 5% in the control group. After 20 minutes of reper fusion, dP/dt (first-time derivative of the ventricular pressure) in the agmatine group reached full recovery of 106% ± 12% versus only 64% ± 14% in the saline group (P = .059). Agmatine also caused a significant increase in coronary flow rate (P < .004) through out the reperfusion period. Quantitative immunohistochemical staining disclosed reduced cell damage in the agmatine-treated hearts (P < .02) versus the control group.
Conclusion: Agmatine injection given before induced ischemia improves hemodynamic recovery by mechanisms that may be attributed to its vasodilatory properties.
Pegg A., Peter F., McCann P.Polyamines metabolism and function. Cell Physiol12c:212, 1982
2.
Gilad GM, Gilad V.Polyamines in neurotrauma ubiquitous molecules in search for function . Biochem Pharmacology44:401, 1992
3.
Paschem W.Polyamine metabolism in different pathological states of the brain . Mol Chem Neuropathol16:241, 1992
4.
Higki I., Matsui I., Yuasada L.The effect of hepatic ischemia reperfusion on polyamines metabolism in some rat organs. Transplantation55:268, 1993
5.
Terakura M., Higaki I., Matsui I.Polyamine metabolism in rat liver after orthotopic transplantation . Biochim Biophys Acta2:207, 1995
6.
Gilad GM, Gilad V.Polyamines can protect against ischemia induced nerve cell death in gerbil forebrain. Exp Neurol111:349, 1991
7.
Tagliavini S. , Genedani S., Bertolini A., et al. Ischemia and reperfusion induced arrhythmias are prevented by putrescine. Eur J Pharmacol194:7, 1991
8.
Matkovics B. , Kecskemeti V., Varga SI, et al. Antioxidant properties of di- and polyamines. Comp Biochem Physiol104:475, 1993
9.
Finkelstein A., Gilad GM, Edelman G., et al. Plasma polyamines in coronary syndromes (Abstract). J Isr Heart Soc32:32, 1996
10.
Gehn L., Regunathan CJ, Coline J., et al. Agmatine: An endogenous clonidine displacing substance in the brain. Science263:966, 1994
11.
Loring RHAgmatine act as antagonist of neural nicotinic receptors. Br J Pharmacol99:207,1990
12.
Reynolds JIArcaine uncovers dual interaction of polyamines with the N-methyl-D-aspartate receptors. J Pharmacol Exp Ther225:1001, 1990
13.
Yang XC, Reis DJAgmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J Pharmacol Exp Ther288:544,1999
14.
Hong JX, Haun RS, Tsai SC, et al. Effect of amino factor terminal deletion on its GTP dependent stimulation of cholera toxin activity. J Biol Chem269:9743, 1994
15.
Thiemermann C., Bowe J., Myint F., et al. Inhibition of the activity of poly (ADP ribose) synthetase reduces ischemiareperfusion injury in heart and skeletal muscle. Proc Natl Acad Sci U S A94:679, 1997
16.
Sun MK, Regunathan S., Reis DGCardiovascular response to agmatine clonidine displacing substance in anesthetized rats. Clin Exp Hypertens17:112, 1995
17.
Zabo S., Urbane R., Limberger N., et al. Cardiovascular effect of agmatine a clonidine displacing substance in conscious rabbit. Naugh SchmiedebergArch Pharmacol35:268, 1995
18.
Gao Y., Gumusel B., Kovers G., et al. Agmatine, a novel endogenous vasodilator substance. Life Sci57:83, 1995
19.
Lortei MG, Novotny WF, Peterson OW, et al. Agmatine a bioactive metabolite production, degradation, and functional effect in the kidney of the rat. J Clin Invest97:413, 1996
20.
Shultz R., Wambolt R.Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischemia-reperfusion injury. Cardiovasc Res30:432, 1995
21.
Gilad GM, Slamiek K., Rabey JM, et al. Agmatine treatment is neuroprotective in rodent brain injury models. Life Sci58:411,1996
22.
Doran JP, Howie AJ, Townened JN, et al. Detection of myocardial infarction by wax embedded section. J Clin Pathol49:34,1996
23.
Ernsberger P., Haxhiu MAThe I1 imidazoline binding site is a functional receptor mediating vasodepression via the ventral medula . Am J Physiol42:1572, 1997
24.
Regunathan S., Youngson C., Raach W., et al. Imidazoline receptors and agmatine in blood vessels: A novel system inhibiting vascular smooth muscle cell proliferation . J Pharmacol Exp Ther276:1272, 1996
25.
Regunathan S., Reis DJStimulation of imidazoline receptors inhibits proliferation of human coronary artery vascular smooth muscle cells . Hypertension30:295, 1997
26.
Morrissey JJ , Klahr S.Agmatine activation of nitric oxide synthase in endothelial cells. Proc Assoc Am Physicians109:51, 1997
27.
Moldering GJ , Likungu J., Jakschik J., et al. Presynaptic imidazoline receptors and non-aderenoceptors (3H)-idazoxan binding sites in human cardiovascular tissues. Br J Pharmacol122:43, 1997
28.
Gilad GM, Wollman Y., Iaina A., et al. Metabolism of agmatine into urea but not into nitric oxide in rat brain. Neuroreport7:1730,1996
29.
Galea E., Regunathan S., Eliopoulos V., et al. Inhibition of mammalian nitric oxide synthase by agmatine, an endogeneous polyamine formed by decarboxylation of arginine. Biochem J316:247,1996
30.
Tsuchina M. , Shimoyama M.Target protein for eucaryotic arginine-specific ADP-ribosyltransferase. Mol Cell Biochem138:113, 1994
31.
Gilad E., Zingarelli B., Salzman AL, et al. Protection of inhibition of poly(ADP-ribose) synthase against oxidant injury in cardiac myoblasts in vitro. J Mol Cell Cardiol29:2585, 1997
32.
Bowes J., Thiemermann C.Effect of inhibitors of the activity of poly (ADP-ribose) synthetase on liver injury caused by ischemia-reperfusion: A comparison with radical scavengers . Br J Pharmacol124:1254, 1998
33.
Satriano J. , Matsufuji S., Murakami Y., et al. Agmatine suppresses proliferation by frameshift induction of antienzyme and attenuation of cellular polyamines level. J Biol Chem273:15313, 1998
34.
Raasch W.Regunathan CJ, Li G., et al. Agmatine, a bacterial amine widely distributed in mammalian tissue. Life Sci56:2319, 1995
35.
Gilad GM, Gilad VH, Rabey JMArginine and ornitine decarboxylation in rodent brain: Coincidental changes during development and after ischemia. Neurosci Lett216:33, 1996
